IL-1β is responsible for the infiltration of myeloid cells, primarily MDSCs, CD11b+Gr-1+ granulocytes, and CD11b+F4/80+Gr-1−/low TAMs in the tumor microenvironment, thereby promoting tumor growth, progression, and poor prognosis[60,61]. The gene discussed is IL1B; the disease is neoplasm.